|Previous Section||Index||Home Page|
|Estimated cost (£000)|
| Source: IMS HEALTH: Hospital Pharmacy Audit|
Mr. Lansley: To ask the Secretary of State for Health how many prescriptions for anti-depressants were dispensed in the community in each year since 1997; and how many of those were dispensed to children in each year. 
Caroline Flint: Anti-depressant drugs are classified under section 4.3 of the British National Formulary and the information in the following table is provided on this basis. Estimated figures are based on a sample of 1 in 20 prescriptions and have been grossed up to reflect the population totals and rounded.
|BNF 4.3 -prescription items dispensed (thousand)||Estimate of prescription items dispensed for children (thousand)||Percentage dispensed to children|
| Source: Prescription cost analysis system.|
(3) if she will estimate the savings which would accrue to the NHS if primary care trusts with the highest rates of hospital admissions for asthma were to reduce their admissions to the average rate. 
a register of patients diagnosed with, and prescribed drugs for, asthma;
a record of patients aged eight years and over where diagnosis confirmed by spirometry or peak flow measurement; and
a record of asthma review within past 15 months.
Ms Rosie Winterton: On 24 January 2007, the National Institute for Health and Clinical Excellence (NICE) issued guidance to the national health service on the use of cetuximab for the treatment of metastatic colorectal cancer.
NICE'S guidance did not recommend cetuximab as a treatment option for metastatic colorectal cancer. However, the guidance states that patients who were receiving cetuximab should have the option to continue to do so until they and their consultants decide that it is the right time to stop treatment.
Mr. Nicholas Brown: To ask the Secretary of State for Health what progress has been made in reducing waiting times for the treatment of (a) cancer and (b) heart disease; and what the average waiting time is for treatment of each condition in (i) Newcastle Primary Care Trust area, (ii) North Tyneside Primary Care Trust area and (iii) England. 
Ms Rosie Winterton: Over the past year, the national health service has made excellent progress on cancer waiting times with full achievement of both the 31-day target and the 62-day target. In quarter 3, 2006-07, performance nationally against these standards was 99.6 per cent. and 96.3 per cent. respectively. For the same period, the performance of the Newcastle-upon-Tyne hospitals NHS trust against these targets was 99.6 per cent. and 96.1 per cent. respectively.
Provisional data at 31 March 2007 indicate that 5,967 people in England were waiting for a heart operation, none of whom were waiting over three months. 136 of these were waiting for treatment at the Newcastle-upon-Tyne hospitals NHS trust.
Helen Jones: To ask the Secretary of State for Health how much was (a) allocated to and (b) spent by each local authority in England to provide services for carers in the last year for which figures are available. 
The grant is no longer ring-fenced and the Department does not collect data about how much each council spends supporting carers. However, councils do have a duty to support them and they should be taking carers' needs into account when planning and commissioning all services.
Mr. Lansley: To ask the Secretary of State for Health when she expects to publish data relating to cases of Clostridium difficile in all those aged two years and over for each NHS trust in England; and for what reasons she does not plan to include such cases of Clostridium difficile in the Clostridium difficile mandatory surveillance system. 
Mr. Ivan Lewis: The Health Protection Agency (HPA) publishes data regarding the mandatory surveillance scheme for Clostridium difficile associated disease (CDAD) on its website: www.hpa.org.uk/hpa/news/articles/press_releases/2007/070426_clostridium _mrsa.htm. The scheme began in January 2004 and up until 31 March 2007 all acute NHS trusts had to report all cases of CDAD for patients aged 65 years and over.
Since 1 April 2007 it is mandatory for all acute NHS trusts to report all cases of CDAD in all patients aged two years and over. HPA plan to publish first quarter data (1 April-30 June 2007) on all cases of CDAD in patients aged two years and over, in October 2007.
Mr. Watson: To ask the Secretary of State for Health how many NHS dentists were employed in (a) West Bromwich East constituency and (b) the West Midlands region in each of the last three years. 
Ms Rosie Winterton: Numbers of national health service dentists in West Bromwich East constituency and the former Birmingham and the Black Country strategic health authority (SHA) from 31 March 1997 to 31 March 2006 are available in annex E and G of the NHS Dental Activity and Workforce Report England: 31 March 2006. The report is available in the Library and online at:
Information on the dental work force under the new dental contractual arrangements introduced on 1 April 2006 is published every quarter by The Information Centre for health and social care. These data are not comparable with the historical data prior to this date.
Mr. Hurd: To ask the Secretary of State for Health what estimate she has made of expenditure by her Department in each of the Government office regions in the most recent year for which figures are available. 
The MHRA's total spend for the financial year 2005-06 was £74.8 million. This is not split into regions as the MHRA has no regional offices. The MHRA's accounts are published annually and the latest covering the financial year 2005-06 was published in October 2006 and can be accessed online through the following link:
Mr. Ivan Lewis [holding answer 8 May 2007]: The Department orders red boxes from Banner Business Supplies as and when they are needed. Ministerial boxes are used by successive Ministers over many years.
Mr. Lansley: To ask the Secretary of State for Health pursuant to the answer of 1 May 2007, Official Report, column 1601W, on diabetes: screening, how many people offered retinopathy screening were screened for diabetic retinopathy in (a) each year since 2003-04 and (b) the most recent period for which figures are available. 
|Number of people with diabetes receiving screening for diabetic retinopathy( 1)|
|(1) Data from local delivery plans returns. (2) Data for year 2003-04 was an incomplete return.|
|Diamorphinenumber of prescription items (thousand)|
| Source: Prescription Cost Analysis system|
|Next Section||Index||Home Page|